Invasion of human microvascular endothelial cells by Mycobacterium leprae through Mce1A protein.


Journal

The Journal of dermatology
ISSN: 1346-8138
Titre abrégé: J Dermatol
Pays: England
ID NLM: 7600545

Informations de publication

Date de publication:
Oct 2019
Historique:
received: 24 04 2019
accepted: 22 07 2019
pubmed: 23 8 2019
medline: 14 11 2019
entrez: 22 8 2019
Statut: ppublish

Résumé

In patients with lepromatous leprosy, Mycobacterium leprae is often observed inside the human microvascular endothelial cells (HMVEC) surrounding Schwann cells (SC) at the site of lesions in the peripheral nerves. Based on this observation, it is considered that the nasal mucous may be the invasion pathway for M. leprae and HMVEC serve as an important reservoir for the bacteria before they invade SC. In light of previous research which revealed that Mce1A protein mediates bacterial invasion into nasal epithelial cells and HMVEC, we conducted a study to determine whether the invasion of M. leprae into HMVEC can be suppressed by blocking the Mce1A protein. In this study, we analyzed bacterial invasive activity by adding recombinant Escherichia coli, which express the active region (InvX:72 a.a.) of Mce1A protein on their external membrane, into cultured HMVEC, using the adhesin involved in the diffuse adherence mechanism. The number of bacteria that invaded into the cells was then measured by a colony counting method. The active region of Mce1A was divided into four sections, and hyperimmune antisera was prepared for each section for analyzing the inhibitory effect against invasion. The invasive activity was suppressed by antibodies against InvX regions 1-24 a.a., 25-46 a.a. and 58-72 a.a. This suggests that the InvX regions 1-24 a.a., 25-46 a.a. and 58-72 a.a. of Mce1A protein play an important role in the invasion of M. leprae into HMVEC and that it may be possible to suppress entry of M. leprae in HMVEC with antibodies against these regions.

Identifiants

pubmed: 31432529
doi: 10.1111/1346-8138.15047
doi:

Substances chimiques

Antibodies, Bacterial 0
Bacterial Proteins 0
Immune Sera 0
Mce1A protein, Mycobacterium leprae 0
Recombinant Proteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

853-858

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2019 Japanese Dermatological Association.

Références

Sasaki S, Takeshita F, Okuda K, Ishii N. Mycobacterium leprae and leprosy: a compendium. Microbiol Immunol 2001; 45: 729-736.
Walker SL, Lockwood DN. The clinical and immunological features of leprosy. Br Med Bull 2006; 77-78: 103-121.
van Beers SM, de Wit MY, Klatser PR. The epidemiology of Mycobacterium leprae: recent insight. FEMS Microbiol Lett 1996; 136: 221-230.
Scollard DM, McCormick G, Allen JL. Localization of Mycobacterium leprae to endothelial cells of epineurial and perineurial blood vessels and lymphatics. Am J Pathol 1999; 154: 1611-1620.
Scollard DM. Endothelial cells and the pathogenesis of lepromatous neuritis:insights from the armadillo model. Microbes Infect 2000; 2: 1835-1843.
Arruda S, Bomfim G, Knights R, Huima-Byron T, Riley LW. Cloning of an M. tuberculosis DNA fragment associated with entry and survival inside cells. Science 1993; 261: 1454-1457.
Sato N, Fujimura T, Masuzawa M et al. Recombinant Mycobacterium leprae protein associated with entry into mammalian cells of respiratory and skin components. J Dermatol Sci 2007; 46: 101-110.
Fadlitha VB, Yamamoto F, Idris I et al. The unique tropism of Mycobacterium leprae to the nasal epithelial cells can be explained by the mammalian cell entry protein 1A. PLoS Negl Trop Dis 2019; 13: e0006704.
Masuzawa M, Fujimura T, Hamada Y et al. Establishment of a human hemangiosarcoma cell line (ISO-HAS). Int J Cancer 1999; 85: 305-308.
Elsinghorst EA. Measurement of invasion by gentamicin resistance. Methods Enzymol 1994; 236: 405-420.
Rambukkana A, Salzer JL, Yurchenco PD, Tuomanen EI. Neural targeting of Mycobacterium leprae mediated by the G domain of the laminin-2 chain. Cell 1997; 88: 811-821.
Rambukkana A, Yamada H, Zanazzi G et al. Role of a-dystroglycan as a Schwann cell receptor for Mycobacterium leprae. Science 1998; 282: 2076-2079.
Shimoji Y, Ng V, Matsumura K, Fischetti VA, Rambukkana A. A 21-kDa surface protein of Mycobacterium leprae binds peripheral nerve laminin-2 and mediates Schwann cell invasion. Proc Natl Acad Sci U S A 1999; 96: 9857-9862.
Ng V, Zanazzi G, Timpl R et al. Role of the cell wall phenolic glycolipid-1 in the peripheral nerve predilection of Mycobacterium leprae. Cell 2000; 103: 511-524.
Boyaka PN. Inducing mucosal IgA: a challenge for vaccine adjuvants and delivery systems. J Immunol 2017; 199: 9-16.

Auteurs

Irfan Idris (I)

Hasanuddin University Medical Research Center, Makassar, Indonesia.
Departments of, Departments of, Dermatology, Kitasato University Graduate School of Medical Science, Sagamihara, Japan.

Ahmad Haykal Abdurrahman (AH)

Hasanuddin University Medical Research Center, Makassar, Indonesia.
Departments of, Departments of, Dermatology, Kitasato University Graduate School of Medical Science, Sagamihara, Japan.
Departments of, Departments of, Dermatology, Kitasato University Graduate School of Medical Science, Sagamihara, Japan.

Vienza Beby Aftitah (VB)

Cellular Immunology, Kitasato University Graduate School of Medical Science, Sagamihara, Japan.

Viesta Beby Fadlitha (VB)

Departments of, Departments of, Dermatology, Kitasato University Graduate School of Medical Science, Sagamihara, Japan.

Naoya Sato (N)

Department of Dermatology, Toshiba Rinkan Hospital, Sagamihara, Japan.
Departments of, Departments of, Dermatology, Kitasato University School of Medicine, Sagamihara, Japan.

Takao Fujimura (T)

Departments of, Departments of, Dermatology, Kitasato University Graduate School of Medical Science, Sagamihara, Japan.
Departments of, Departments of, Dermatology, Kitasato University School of Medicine, Sagamihara, Japan.

Hiroaki Takimoto (H)

Bioscience, Kitasato University School of Science, Sagamihara, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH